Liver Diseases  >>  GI-5005  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
GI-5005 / GlobeImmune
NCT00606086 / 2007-005385-12: Safety and Efficacy of the Therapeutic Vaccine GI-5005 Combined With Pegylated Interferon Plus Ribavirin Standard of Care Therapy Versus Standard of Care Alone in Patients With Genotype 1 Chronic Hepatitis C Infection

Completed
2
140
US
GI-5005, Pegasys and Ribavirin, Pegylated Interferon and Ribavirin
GlobeImmune
Genotype 1 Chronic Hepatitis C
11/12
11/12

Download Options